Title |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Abstract |
1 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Background and objectives |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Target population and subgroups |
1 |
0 |
1 |
1 |
1 |
0 |
0 |
0 |
0 |
Setting and location |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
1 |
Study perspective |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Comparators |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Time horizon |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Discount rate |
0 |
0 |
1 |
1 |
1 |
1 |
0 |
1 |
1 |
Choice of health outcomes |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Measurement of effectiveness |
0 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
Measurement and valuation of preference based outcomes |
0 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Estimating resources and costs |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Currency, price date, and conversion |
0 |
1 |
1 |
1 |
0 |
1 |
0 |
1 |
1 |
Choice of model |
0 |
0 |
1 |
0 |
1 |
0 |
1 |
0 |
1 |
Assumptions |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
1 |
Analytical methods |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Study parameters |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Incremental costs and outcomes |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Characterizing uncertainty |
1 |
1 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
Characterizing heterogeneity |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
Study findings, limitations, generalizability, and current knowledge |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Source of funding |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
1 |
1 |
Conflicts of interest |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Total |
18 |
17 |
22 |
22 |
22 |
21 |
19 |
20 |
22 |
Ratio |
0.75 |
0.71 |
0.92 |
0.92 |
0.92 |
0.88 |
0.79 |
0.83 |
0.92 |
Quality |
Fair |
Fair |
Good |
Good |
Good |
Good |
Fair |
Good |
Good |
Section item
|
Levy et al. (21)
|
Kumar et al. (22)
|
Nguyen et al. (18)
|
Nordyke et al. (27)
|
O'Sullivan et al. (26)
|
Jo et al. (23)
|
Whetten et al. (17)
|
Cleghorn et al. (24)
|
Islam et al. (11)
|
Title |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Abstract |
0 |
1 |
1 |
1 |
1 |
0 |
1 |
1 |
0 |
Background and objectives |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Target population and subgroups |
1 |
1 |
1 |
0 |
1 |
0 |
0 |
0 |
0 |
Setting and location |
1 |
1 |
1 |
0 |
1 |
1 |
1 |
1 |
1 |
Study perspective |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Comparators |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Time horizon |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Discount rate |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
1 |
1 |
Choice of health outcomes |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Measurement of effectiveness |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
1 |
1 |
Measurement and valuation of preference based outcomes |
1 |
1 |
1 |
1 |
1 |
0 |
1 |
1 |
1 |
Estimating resources and costs |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Currency, price date, and conversion |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Choice of model |
0 |
1 |
1 |
1 |
0 |
1 |
1 |
1 |
1 |
Assumptions |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Analytical methods |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Study parameters |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Incremental costs and outcomes |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Characterizing uncertainty |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Characterizing heterogeneity |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
Study findings, limitations, generalizability, and current knowledge |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Source of funding |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Conflicts of interest |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Total |
21 |
23 |
23 |
21 |
22 |
20 |
21 |
23 |
21 |
Ratio |
0.88 |
0.96 |
0.96 |
0.88 |
0.92 |
0.83 |
0.88 |
0.96 |
0.88 |
Quality |
Good |
Good |
Good |
Good |
Good |
Good |
Good |
Good |
Good |
Section item
|
Hoyo et al. (30)
|
Modi et al. (39)
|
Lowry et al. (14)
|
Witt Udsen et al. (34)
|
Romero-Sanchiz et al. (35)
|
Lugo et al. (9)
|
Oksman et al. (20)
|
Fusco and Francesco
(31)
|
Lopez-Villegas et al. (37)
|
Title |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Abstract |
1 |
0 |
1 |
0 |
1 |
0 |
0 |
1 |
1 |
Background and objectives |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Target population and subgroups |
1 |
0 |
0 |
1 |
1 |
0 |
0 |
0 |
0 |
Setting and location |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
1 |
Study perspective |
1 |
1 |
0 |
1 |
1 |
1 |
0 |
1 |
1 |
Comparators |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Time horizon |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Discount rate |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
1 |
1 |
Choice of health outcomes |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Measurement of effectiveness |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
1 |
0 |
Measurement and valuation of preference based outcomes |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Estimating resources and costs |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
1 |
1 |
Currency, price date, and conversion |
1 |
1 |
1 |
1 |
1 |
0 |
0 |
1 |
1 |
Choice of model |
0 |
1 |
1 |
1 |
1 |
1 |
0 |
1 |
0 |
Assumptions |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
1 |
1 |
Analytical methods |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Study parameters |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Incremental costs and outcomes |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Characterizing uncertainty |
1 |
1 |
0 |
1 |
1 |
0 |
1 |
1 |
1 |
Characterizing heterogeneity |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
Study findings, limitations, generalizability, and current knowledge |
1 |
1 |
1 |
1 |
1 |
0 |
1 |
1 |
1 |
Source of funding |
1 |
1 |
1 |
0 |
1 |
1 |
1 |
1 |
1 |
Conflicts of interest |
1 |
1 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
Total |
22 |
21 |
19 |
22 |
24 |
18 |
15 |
22 |
21 |
Ratio |
0.92 |
0.88 |
0.79 |
0.92 |
1 |
0.71 |
0.63 |
0.92 |
0.88 |
Quality |
Good |
Good |
Fair |
Good |
Excellent |
Fair |
Average |
Good |
Good |
Section item
|
Wan et al. (10)
|
Watson et al. (32)
|
Buvik et al. (41)
|
Oostingh et al. (12) |
Yoo et al. (33)
|
Krishnan et al. (8)
|
Bahrainwala et al. (15)
|
de Jong et al. (29)
|
Title |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Abstract |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
1 |
Background and objectives |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Target population and subgroups |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
1 |
Setting and location |
1 |
0 |
1 |
0 |
1 |
0 |
1 |
1 |
Study perspective |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Comparators |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Time horizon |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Discount rate |
0 |
0 |
1 |
0 |
1 |
1 |
1 |
0 |
Choice of health outcomes |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Measurement of effectiveness |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Measurement and valuation of preference based outcomes |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Estimating resources and costs |
1 |
0 |
1 |
0 |
1 |
1 |
1 |
1 |
Currency, price date, and conversion |
1 |
1 |
0 |
1 |
1 |
1 |
1 |
0 |
Choice of model |
1 |
1 |
0 |
1 |
1 |
1 |
1 |
1 |
Assumptions |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Analytical methods |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Study parameters |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Incremental costs and outcomes |
1 |
1 |
0 |
1 |
1 |
1 |
1 |
1 |
Characterizing uncertainty |
0 |
0 |
1 |
1 |
1 |
1 |
1 |
1 |
Characterizing heterogeneity |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Study findings, limitations, generalizability, and current knowledge |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Source of funding |
1 |
1 |
1 |
1 |
0 |
1 |
1 |
1 |
Conflicts of interest |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
Total |
19 |
17 |
18 |
19 |
21 |
21 |
21 |
21 |
Ratio |
0.79 |
0.71 |
0.75 |
0.79 |
0.88 |
0.88 |
0.88 |
0.88 |
Quality |
Fair |
Fair |
Fair |
Fair |
Good |
Good |
Good |
Good |